Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

Viagra patent expiry opens up market

June 24, 2013
Manufacturing and Production, Research and Development, Sales and Marketing ED, Pfizer, generics, viagra

Pfizer lost its UK patent rights to its erectile dysfunction drug Viagra over the weekend, leading to an influx of …

News
Teva image

Pfizer wins $2.15 billion patent case

June 13, 2013
Sales and Marketing Pfizer, Takeda, Teva, protonix

Pfizer and Takeda are to split $2.15 billion in damages from two generics manufacturers as a settlement for lost sales, …

News
kim_sinil_4

Mirna appoints ex-Pfizer senior director

June 6, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, miRNA

Biotech firm Mirna Therapeutics has appointed Dr Sinil Kim as vice president of Oncology and chief medical officer. Kim will …

Appointment

Pfizer, UCB sell plants to smaller drugmakers

May 30, 2013
Manufacturing and Production Pfizer, UCB

This week saw two pharma companies offload US manufacturing facilities to contract manufacturing organisations (CMOs), with Pfizer selling a plant …

News
pfizerworld

Pfizer abandons cancer trial

May 22, 2013
Research and Development, Sales and Marketing Cancer, Inotuzumab ozogamicin, Pfizer, oncology

Pfizer’s oncology pipeline has suffered a blow with the company abandoning a Phase III study of one of its investigational …

News
Pfizer image

Pfizer targets Newcastle

May 15, 2013
Research and Development, Sales and Marketing ABPI, Cameron, NHS, Newcastle, Pfizer

Pfizer has earmarked Newcastle Hospitals NHS Foundation Trust as one of 60 sites worldwide to take part in a key …

News

New Viagra site launched

May 10, 2013
Manufacturing and Production, Medical Communications, Sales and Marketing ED, Pfizer, viagra

Pfizer has launched a new sales website for Viagra, the ‘little blue pill’ which is its most counterfeited medicine, to …

News

Pfizer sales shrink 9 per cent

April 30, 2013
Sales and Marketing Ian Read, Lipitor, Pfizer

Pfizer endured another painful cut to its revenues in the first quarter of 2013, with sales down $1.4 billion, or …

News

Pfizer and Merck create major diabetes alliance

April 30, 2013
Research and Development, Sales and Marketing Merck, Pfizer, diabetes

Pfizer and Merck have unveiled a major new alliance in diabetes which is likely to raise the stakes in the …

News

Pfizer’s Xeljanz rejected in Europe

April 28, 2013
Sales and Marketing CHMP, Humira, Pfizer, RA, Xeljanz, rheumatoid arthritis

Pfizer has suffered a major setback with the rejection of its new arthritis drug in Europe.The EMA’s medicines committee the …

News
stephen-williams

Venaxis appoints former Pfizer executive to Board of directors

April 19, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, venaxis, williams

Diganostic firm Venaxis has appointed SomaLogic’s chief medical officer Stephen Williams to the company’s Board of directors.  

Appointment
celgene_hugin

Big pharma appointments to PhRMA Board

April 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, Celgene, Merck, Pfizer, PhRMA

Chairman and chief executive of Celgene Robert Hugin has been elected chairman of the Pharmaceutical Research and Manufacturers of America …

Appointment
Eliquis image

Eliquis approved by NICE

February 28, 2013
Sales and Marketing BMS, Eliquis, NICE, Pfizer

In a move which will cheer Bristol-Myers Squibb and Pfizer, NICE has recommended oral blood-thinner Eliquis for use on the …

News

Sanofi won’t follow trend for spin-offs

February 8, 2013
Sales and Marketing Abbott, Pfizer, Sanofi, Viehbacher

Sanofi’s chief executive Chris Viehbacher says the firm plans to maintain its portfolio of business divisions for the foreseeable future, …

News

CHMP nod for Pfizer CML drug

January 21, 2013
Sales and Marketing CHMP, CML, FDA, Pfizer

Pfizer’s cancer drug bosutinib has been given a positive opinion by the CHMP for patients with chronic myelogenous leukemia (CML). …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026